GO:0070936 protein K48-linked ubiquitination: Degradation Signal, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070936 (protein K48-linked ubiquitination) describes the attachment of a ubiquitin polymer linked through lysine 48 of ubiquitin monomers to a substrate protein, a modification that classically targets the substrate for proteasomal degradation.
• K48-linked chains are assembled by an E1-E2-E3 enzymatic cascade and are recognized by proteasome-associated ubiquitin receptors, making this process a central node of protein quality control.
• The same K48-linked ubiquitination machinery controls diverse substrates, including P53 in esophageal squamous cell carcinoma, SLC7A11 in hepatocellular carcinoma, NR4A1 in mesangial proliferative glomerulonephritis, and viral NS2A during flavivirus infection.
• K48-linked ubiquitination is not only degradative: it also participates in translation-coupled resolution of RNA-protein crosslinks through RNF14-dependent atypical ubiquitylation and in cold-stress signaling through PUB25/PUB26-mediated ICE1 turnover in Arabidopsis.
• Dysregulation of K48-linked ubiquitination is implicated in cancer, kidney disease, viral pathogenesis, and plant stress responses, making it a broad therapeutic and research target [2,3,4,5,7,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which E3 ligases and substrates mediate specific K48-linked ubiquitination events in disease [2,4,5].
Description
Protein K48-linked ubiquitination (GO:0070936) is a biological process in which a polyubiquitin chain assembled through isopeptide bonds between lysine 48 residues of ubiquitin monomers is conjugated to a substrate protein. This modification is one of the most intensively studied post-translational signals because it typically marks the modified protein for degradation by the 26S proteasome, thereby controlling protein half-life, quality control, and signaling output. The reaction depends on the sequential action of ubiquitin-activating (E1), ubiquitin-conjugating (E2), and ubiquitin-ligating (E3) enzymes, and its specificity is largely determined by the E3 ligase that recognizes the substrate. Researchers care about GO:0070936 because it sits at the intersection of proteostasis and disease. For example, TRIM33 promotes glycolysis by regulating P53 K48-linked ubiquitination to drive esophageal squamous cell carcinoma growth, and SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. In kidney disease, Bruceine A protects nuclear receptor 4A1 from ubiquitin-degradation to alleviate mesangial proliferative glomerulonephritis. In virology, AMFR-mediated K48-linked ubiquitination of flavivirus NS2A subverts ER-phagy to augment viral pathogenicity. These examples illustrate that K48-linked ubiquitination is a tractable node for therapeutic intervention and a frequent subject of CRISPR-based functional genomics [2,3,4,5]. Beyond degradation, K48-linked ubiquitination also contributes to translation-coupled quality control. RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks, and in plants, PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress. A recent review further highlights the roles of K48- and K63-linked ubiquitination in plant development and stress responses. Together, these studies establish GO:0070936 as a fundamental process with broad relevance across human disease and plant biology [2,3,4,5,6,7,8].
protein K48-linked ubiquitination At A Glance
| GO ID | GO:0070936 |
|---|---|
| GO term | protein K48-linked ubiquitination |
| Ontology | biological_process |
| Synonym | protein K48-linked polyubiquitination |
| Definition | A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein; K48-linked ubiquitination targets the substrate protein for degradation. |
| Major function | Targets substrate proteins for proteasomal degradation and participates in proteostasis, signaling, and stress responses. |
| Enzymatic requirement | Requires E1 activating, E2 conjugating, and E3 ligating enzymes to assemble and transfer the K48-linked chain. |
| Representative substrates | P53, SLC7A11, NR4A1, flavivirus NS2A, ICE1. |
| Disease relevance | Cancer [2,4], kidney disease, viral pathogenesis, and plant stress responses [7,8]. |
What Is GO:0070936?
GO:0070936 (protein K48-linked ubiquitination) is defined as a protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein; K48-linked ubiquitination targets the substrate protein for degradation. In other words, it is the enzymatic construction and attachment of a K48-linked polyubiquitin chain onto a target protein, a signal that is classically decoded by the proteasome.
Why Is protein K48-linked ubiquitination Important in Cell Biology?
GO:0070936 is important because K48-linked ubiquitination is a principal mechanism by which cells control protein stability and eliminate damaged or unwanted proteins. Its dysregulation contributes to cancer, kidney disease, and viral pathogenesis, and it is a central node in plant stress signaling [2,3,4,5,7,8]. Because the process is enzyme-driven and substrate-specific, it offers numerous points for experimental perturbation and therapeutic targeting [2,3,4,5].
• Controls protein half-life by targeting substrates for proteasomal degradation.
• Regulates oncoproteins and tumor suppressors such as P53 in esophageal squamous cell carcinoma.
• Modulates ferroptosis and radiosensitivity through SLC7A11 degradation in hepatocellular carcinoma.
• Protects or destabilizes nuclear receptors such as NR4A1 in mesangial proliferative glomerulonephritis.
• Supports viral pathogenicity via AMFR-mediated NS2A ubiquitination and ER-phagy subversion.
• Participates in translation-coupled resolution of RNA-protein crosslinks via RNF14.
• Controls cold-stress signaling through PUB25/PUB26-mediated ICE1 turnover in Arabidopsis.
• Is a major theme in plant development and stress responses alongside K63-linked ubiquitination.
• Provides a rich source of E3 ligase targets for CRISPR functional genomics [2,4,5].
• Offers mechanistic biomarkers and intervention points across multiple disease areas [2,3,4,5].
What Happens During protein K48-linked ubiquitination?
Substrate recognition by E3 ligases
In simple terms: The E3 ligase chooses which protein gets tagged.
The specificity of K48-linked ubiquitination is largely determined by E3 ubiquitin ligases that recognize substrate degrons or modified surfaces. For example, TRIM33 regulates P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth, and SOCS2 enhances ubiquitination of SLC7A11 to promote ferroptosis and radiosensitization in hepatocellular carcinoma. In kidney disease, Bruceine A protects nuclear receptor 4A1 from ubiquitin-degradation, indicating that substrate recognition is pharmacologically tractable.
Chain assembly through E1-E2-E3 cascade
In simple terms: A relay of enzymes builds the K48-linked chain.
K48-linked polyubiquitin chains are assembled by the sequential action of E1 activating, E2 conjugating, and E3 ligating enzymes, with ubiquitin monomers linked through lysine 48. This enzymatic cascade ensures that the chain is built on the correct substrate and with the correct linkage type. In plants, PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress, illustrating how E3 ligases shape chain topology and substrate fate.
Proteasomal targeting and degradation
In simple terms: The K48 chain acts as a ticket to the proteasome.
K48-linked ubiquitination targets the substrate protein for degradation, meaning the modified protein is recognized by proteasome-associated receptors and delivered to the 26S proteasome. This degradative outcome underlies many of the disease-relevant phenotypes described for K48-linked ubiquitination, including P53 turnover in cancer and SLC7A11 degradation in ferroptosis.
Non-degradative and atypical roles
In simple terms: K48 chains can also do jobs beyond simple destruction.
Although K48-linked ubiquitination is classically degradative, emerging evidence shows atypical roles. RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks. In flavivirus infection, AMFR-mediated NS2A ubiquitination subverts ER-phagy to augment viral pathogenicity. These examples show that K48-linked ubiquitination can intersect with quality control and autophagy pathways beyond the proteasome [5,6].
Stress-responsive and developmental contexts
In simple terms: The process is tuned to environmental and developmental cues.
K48-linked ubiquitination is dynamically regulated during stress. In Arabidopsis, PUB25 and PUB26 modulate ICE1 stability during cold stress. A recent review highlights the roles of K48- and K63-linked ubiquitination in plant development and stress responses. These findings indicate that K48-linked ubiquitination is not a static degradation signal but a regulated process integrated with environmental sensing [7,8].
Key Genes Involved in GO:0070936 protein K48-linked ubiquitination
The following genes and proteins are experimentally linked to K48-linked ubiquitination or its substrate regulation in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRIM33 | E3 ligase regulating P53 K48-linked ubiquitination | Promotes glycolysis and esophageal squamous cell carcinoma growth |
| P53 | Tumor suppressor substrate of K48-linked ubiquitination | Degradation via TRIM33 drives cancer metabolism |
| SOCS2 | E3 ligase enhancing SLC7A11 ubiquitination | Promotes ferroptosis and radiosensitization in hepatocellular carcinoma |
| SLC7A11 | Cystine transporter substrate of K48-linked ubiquitination | Degradation triggers ferroptosis and radiosensitization |
| NR4A1 | Nuclear receptor protected from ubiquitin-degradation | Bruceine A alleviates mesangial proliferative glomerulonephritis |
| AMFR | E3 ligase mediating NS2A ubiquitination | Subverts ER-phagy to augment flavivirus pathogenicity |
| NS2A | Flavivirus protein substrate of AMFR-mediated ubiquitination | Viral pathogenicity and ER-phagy subversion |
| RNF14 | E3 ligase mediating atypical ubiquitylation | Translation-coupled resolution of RNA-protein crosslinks |
| PUB25 | E3 ligase modulating ICE1 stability | Cold stress response in Arabidopsis |
| PUB26 | E3 ligase modulating ICE1 stability | Cold stress response in Arabidopsis |
| ICE1 | Transcription factor substrate of PUB25/PUB26 | Cold stress signaling in Arabidopsis |
| STING | Immune adaptor with ubiquitination-related regulation | ISGylation by HERCs facilitates STING activation |
| HERC proteins | E3 ligases mediating ISGylation | Facilitate STING activation |
| Ubiquitin | Polymer building block linked at K48 | Forms K48-linked chains targeting substrates for degradation |
| Proteasome receptors | Decode K48-linked chains | Deliver substrates for degradation |
| E1 enzymes | Activate ubiquitin | Initiate the ubiquitination cascade |
| E2 enzymes | Conjugate ubiquitin | Transfer ubiquitin to substrates with E3 ligases |
| E3 ligases | Recognize substrates and build K48 chains | Determine specificity of K48-linked ubiquitination |
How Is protein K48-linked ubiquitination Regulated?
K48-linked ubiquitination is regulated at multiple levels. Substrate recognition by E3 ligases determines which proteins are modified, as shown for TRIM33-P53 and SOCS2-SLC7A11. Chain assembly depends on the E1-E2-E3 cascade, and the linkage type is dictated by the E2 and E3 enzymes involved. Environmental and developmental cues can dynamically modulate the process, as illustrated by PUB25/PUB26-mediated ICE1 turnover during cold stress. In addition, crosstalk with other ubiquitin-like modifications, such as ISGylation by HERCs in STING activation, can influence related signaling outcomes. Pharmacological intervention can also modulate substrate stability, as shown by Bruceine A protecting NR4A1 from ubiquitin-degradation.
protein K48-linked ubiquitination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIM33 | Esophageal squamous cell carcinoma | Knockout and overexpression in ESCC cell lines |
| SLC7A11 | Hepatocellular carcinoma ferroptosis and radiosensitization | Point mutation of ubiquitination sites and KO in HCC cells |
| NR4A1 | Mesangial proliferative glomerulonephritis | Knock-in of degradation-resistant NR4A1 |
| NS2A | Flavivirus pathogenicity | Knock-in of ubiquitination-deficient NS2A in viral clones |
| ICE1 | Cold stress response in Arabidopsis | Knockout and point mutation in plant lines |
K48-linked ubiquitination in cancer
K48-linked ubiquitination controls the stability of oncoproteins and tumor suppressors. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma, linking K48-linked ubiquitination to cell death and therapy response. These studies position K48-linked ubiquitination as a determinant of cancer metabolism and treatment sensitivity [2,4].
K48-linked ubiquitination in kidney disease
In mesangial proliferative glomerulonephritis, Bruceine A protects nuclear receptor 4A1 from ubiquitin-degradation to alleviate disease, indicating that preventing K48-linked degradation of NR4A1 is protective. This highlights the therapeutic potential of modulating K48-linked ubiquitination in kidney disease.
K48-linked ubiquitination in viral pathogenesis
AMFR-mediated Flavivirus NS2A ubiquitination subverts ER-phagy to augment viral pathogenicity, demonstrating that viruses can exploit K48-linked ubiquitination machinery to evade host defenses. This makes the pathway a potential antiviral target.
K48-linked ubiquitination in plant stress and development
In Arabidopsis, PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress. A recent review further discusses K48- and K63-linked ubiquitination in plant development and stress responses. These findings extend the relevance of GO:0070936 beyond human disease to agriculture and plant biology [7,8].
From protein K48-linked ubiquitination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an E3 ligase alter substrate stability? | CRISPR knockout of the E3 ligase [2,4] |
| Which lysine in the substrate is ubiquitinated? | Point mutation of candidate lysine to arginine |
| Does a disease-associated mutation affect K48 chain formation? | Knock-in of the patient mutation |
| Where does the substrate localize after ubiquitination? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of the E3 ligase drive degradation? | Overexpression cell model [2,4] |
| Can a compound protect the substrate from degradation? | Overexpression plus compound treatment |
How to Study the protein K48-linked ubiquitination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunoprecipitation plus ubiquitin immunoblot | Substrate ubiquitination status | Confirm K48-linked modification of a target |
| Mass spectrometry | Ubiquitination site identification | Map lysine residues on substrates |
| CRISPR knockout | Loss-of-function of E3 ligase or substrate | Test causality in cancer cells [2,4] |
| Point mutation | Specific lysine requirement | Determine which residue is ubiquitinated |
| Knock-in | Disease allele or degradation-resistant variant | Model kidney disease or viral pathogenicity [3,5] |
| Overexpression | Gain-of-function of E3 ligase | Drive substrate degradation [2,4] |
| RNA-seq | Transcriptional consequences | Measure metabolic or stress responses [2,4] |
| Proteomics | Global protein stability changes | Identify downstream effectors |
Ubiquitination assays and proteomics
K48-linked ubiquitination can be studied by immunoprecipitation of the substrate followed by immunoblotting with linkage-specific ubiquitin antibodies, or by mass spectrometry to identify ubiquitination sites. These approaches have been used to define substrate modification in cancer and viral infection [2,4,5].
CRISPR functional genomics
CRISPR knockout and point-mutation models allow causal testing of E3 ligases and substrate lysines. For example, knockout of TRIM33 or SOCS2 can reveal effects on P53 or SLC7A11 stability and downstream phenotypes [2,4]. Knock-in of degradation-resistant alleles can test whether preventing K48-linked ubiquitination is sufficient to alter disease phenotypes.
Transcriptomics and proteomics
RNA-seq and proteomics can measure downstream consequences of altered K48-linked ubiquitination, such as metabolic reprogramming in cancer or ferroptosis-related gene expression. These methods help connect molecular changes to pathway-level outcomes [2,4].
Imaging and localization
Fluorescent tagging of substrates or E3 ligases enables tracking of localization and degradation. Tagged knock-in models can reveal whether K48-linked ubiquitination alters subcellular distribution, as seen for viral NS2A and ER-phagy.
How CRISPR Can Be Used to Study GO:0070936 protein K48-linked ubiquitination
Knockout
CRISPR knockout of E3 ligases such as TRIM33 or SOCS2 can abolish K48-linked ubiquitination of their substrates, leading to substrate stabilization and altered phenotypes [2,4]. Knockout models are essential to establish whether a given E3 ligase is required for a specific K48-linked event [2,4].
Point Mutation
Point mutation of the acceptor lysine on a substrate to arginine prevents K48-linked chain formation at that site. This approach has been used to define ubiquitination sites on substrates such as SLC7A11. Point-mutant models help distinguish site-specific effects from global loss of the protein.
Knock-in
Knock-in of degradation-resistant or disease-associated alleles allows testing of whether preventing K48-linked ubiquitination alters disease phenotypes. For example, degradation-resistant NR4A1 protects against mesangial proliferative glomerulonephritis, and ubiquitination-deficient NS2A reduces flavivirus pathogenicity.
Overexpression
Overexpression of an E3 ligase can enhance K48-linked ubiquitination and drive substrate degradation, as shown for TRIM33-mediated P53 turnover and SOCS2-mediated SLC7A11 degradation. Overexpression models are useful for gain-of-function studies and for testing pharmacological protection of substrates.
How EDITGENE Supports protein K48-linked ubiquitination Research
Researchers studying protein K48-linked ubiquitination-related genes often need to determine whether a candidate gene is causally involved in substrate degradation, disease progression, or stress responses. EDITGENE provides CRISPR-based cell models and screening services to interrogate E3 ligases, substrates, and ubiquitination sites with high precision.
Contact EDITGENE today to design your custom CRISPR model for protein K48-linked ubiquitination research.
Frequently Asked Questions About protein K48-linked ubiquitination
What is protein K48-linked ubiquitination?
Protein K48-linked ubiquitination (GO:0070936) is a process in which a polyubiquitin chain linked through lysine 48 of ubiquitin monomers is attached to a substrate protein, typically targeting it for degradation.
What genes are involved in protein K48-linked ubiquitination?
Genes include E3 ligases such as TRIM33, SOCS2, AMFR, RNF14, PUB25 and PUB26, as well as substrates like P53, SLC7A11, NR4A1, NS2A, and ICE1.
How does K48-linked ubiquitination lead to protein degradation?
The K48-linked chain is recognized by proteasome-associated receptors, which deliver the modified protein to the 26S proteasome for degradation.
What is the difference between K48- and K63-linked ubiquitination?
K48-linked ubiquitination typically targets proteins for degradation, whereas K63-linked ubiquitination often regulates signaling and trafficking; both are discussed in plant development and stress responses.
Which diseases are linked to K48-linked ubiquitination?
It is linked to esophageal squamous cell carcinoma, hepatocellular carcinoma, mesangial proliferative glomerulonephritis, and flavivirus pathogenesis.
How can CRISPR be used to study K48-linked ubiquitination?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the roles of E3 ligases and substrate lysines in K48-linked ubiquitination [2,3,4,5].
What is the role of TRIM33 in K48-linked ubiquitination?
TRIM33 regulates P53 K48-linked ubiquitination to promote glycolysis and esophageal squamous cell carcinoma growth.
How does SOCS2 affect SLC7A11 ubiquitination?
SOCS2 enhances ubiquitination of SLC7A11, promoting ferroptosis and radiosensitization in hepatocellular carcinoma.
Can K48-linked ubiquitination be targeted therapeutically?
Yes, compounds such as Bruceine A protect NR4A1 from ubiquitin-degradation and alleviate mesangial proliferative glomerulonephritis, suggesting therapeutic potential.
What methods are used to study K48-linked ubiquitination?
Common methods include immunoprecipitation with linkage-specific ubiquitin antibodies, mass spectrometry, CRISPR models, RNA-seq, and proteomics [2,4,8].
Conclusion
GO:0070936 (protein K48-linked ubiquitination) is a fundamental biological process that controls protein stability through the attachment of K48-linked polyubiquitin chains. Its roles span cancer, kidney disease, viral pathogenesis, and plant stress responses, with E3 ligases such as TRIM33, SOCS2, AMFR, RNF14, PUB25, and PUB26 determining substrate specificity [2,4,5,6,7]. Understanding this process requires integrating enzymatic mechanism, substrate biology, and disease context [2,3,4,5,8]. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, are powerful tools to dissect K48-linked ubiquitination in health and disease [2,3,4,5]. EDITGENE provides these models and screening services to accelerate research on this essential degradation signal.
References
- 1. Qin Y et al.. 2024. ISGylation by HERCs facilitates STING activation.. Cell Rep 43(5):114135 PMID: 38652662
- 2. Xia T et al.. 2024. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth.. Cell Death Dis 15(10):740 PMID: 39389957
- 3. Hu H et al.. 2025. Bruceine A protects nuclear receptor 4A1 from ubiquitin-degradation to alleviate mesangial proliferative glomerulonephritis.. Signal Transduct Target Ther 10(1):397 PMID: 41345104
- 4. Chen Q et al.. 2023. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.. Cell Death Differ 30(1):137-151 PMID: 35995846
- 5. Zhang L et al.. 2024. AMFR-mediated Flavivirus NS2A ubiquitination subverts ER-phagy to augment viral pathogenicity.. Nat Commun 15(1):9578 PMID: 39505910
- 6. Zhao S et al.. 2023. RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks.. Mol Cell 83(23):4290-4303.e9 PMID: 37951216
- 7. Wang X et al.. 2023. PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress in Arabidopsis.. Plant Cell 35(9):3585-3603 PMID: 37279565
- 8. Fan Y et al.. 2026. K48- and K63-linked ubiquitination in plant development and stress responses.. J Genet Genomics 53(5):798-809 PMID: 41482173
